Search alternatives:
greatest decrease » treatment decreased (Expand Search), greater increase (Expand Search)
largest decrease » larger decrease (Expand Search), marked decrease (Expand Search)
nn decrease » _ decrease (Expand Search), mean decrease (Expand Search), gy decreased (Expand Search)
a decrease » _ decrease (Expand Search), _ decreased (Expand Search), _ decreases (Expand Search)
greatest decrease » treatment decreased (Expand Search), greater increase (Expand Search)
largest decrease » larger decrease (Expand Search), marked decrease (Expand Search)
nn decrease » _ decrease (Expand Search), mean decrease (Expand Search), gy decreased (Expand Search)
a decrease » _ decrease (Expand Search), _ decreased (Expand Search), _ decreases (Expand Search)
-
541
-
542
-
543
Effect of <i>slc43a3</i> deletion on physical activity of male and female WT and KO mice.
Published 2025Subjects: -
544
-
545
-
546
-
547
-
548
Survey-weighted association of flavonoids and six subclasses intake with MASLD.
Published 2025Subjects: -
549
-
550
-
551
-
552
Normalized significant family changes in abundance.
Published 2025“…<p>A) <i>Erysipelotrichaceae</i> significantly increased with CCE treatment; B) <i>Bacteroidales_unclassified</i> significantly decreased with CCE treatment; C) <i>Desulfovibrionaceae</i> significantly decreased with CCE treatment; D) <i>Rikenellaceae</i> significantly decreased with CCE treatment; E) <i>Coriobacteriaceae</i> significantly decreased with CCE treatment; F) <i>Erysipelotrichaceae</i> significantly increased with TRE treatment.…”
-
553
-
554
Supplementary Material for: Allopurinol Use is Associated With Decreased Incidence of Hepatic Decompensation and Overall Mortality Among Individuals With Cirrhosis: a Propensity-ma...
Published 2025“…Conclusion: In a propensity-score matched analysis of a large national database, individuals with cirrhosis and allopurinol use had significantly lower risk of hepatic decompensation and overall mortality. …”
-
555
Table 1_A novel α-conotoxin [D1G, ΔQ14] LvIC decreased mouse locomotor activity.xls
Published 2025“…</p>Results<p>The injection of [D1G, ΔQ14] LvIC led to a decrease in locomotor activity in mice. This treatment also resulted in reduced expression of neuronal calcium sensor 1 (NCS-1) and neuroligin 3 (NLGN-3) in the prefrontal cortex (PFC), hippocampus (Hip), and caudate putamen (CPu). …”
-
556
Table 2_A novel α-conotoxin [D1G, ΔQ14] LvIC decreased mouse locomotor activity.xls
Published 2025“…</p>Results<p>The injection of [D1G, ΔQ14] LvIC led to a decrease in locomotor activity in mice. This treatment also resulted in reduced expression of neuronal calcium sensor 1 (NCS-1) and neuroligin 3 (NLGN-3) in the prefrontal cortex (PFC), hippocampus (Hip), and caudate putamen (CPu). …”
-
557
-
558
-
559
-
560